Swedish drugmaker SOBI receives $8bn bid from Advent and Aurora

Swedish drugmaker SOBI receives $8bn bid from Advent and Aurora

Swedish Orphan Biovitrum (SOBI) said on Thursday it had received a bid from U.S. private equity firm Advent International and Aurora Investment valuing the rare disease drugmaker at about $8bn. SOBI’s stock, already up 15% so far this year, rose 24.6% to 239 crowns...
Blackstone Said to Plan IPO of $7bn Building Products Firm

Blackstone Said to Plan IPO of $7bn Building Products Firm

Blackstone is planning an initial public offering for Building Materials Europe BV that could value the business at as much as $7.1bn, people familiar with the matter said. The private equity firm is working with Lazard Ltd. and plans to select underwriters for the...
Dayone Capital Fund I Closes at $630m with Oversubscription

Dayone Capital Fund I Closes at $630m with Oversubscription

Dayone Capital announced today the final closing of Dayone Capital Fund I L.P., its first US-denominated private equity fund, with a total capital commitment exceeding $630m, surpassing the initial fundraising target of 500m. As a debut fund, Dayone Fund I was...